Lumos Diagnostics Holdings (LDX) Short Interest
Lumos Diagnostics Holdings (ASX:LDX) had 0.00% of shares reported as short positions as of 24 Aug 2026, representing 23,448 shares. Lumos Diagnostics Holdings operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Lumos Diagnostics Holdings
Lumos Diagnostics Holdings specializes in the development, manufacture, and distribution of point-of-care diagnostic tests and associated readers. The company is positioned as a leader in rapid diagnostics, offering unique solutions like FebriDx, which aids in differentiating bacterial from viral infections at the point of care.
Short position
Lumos Diagnostics Holdings (ASX:LDX) has 0.00% of its shares on issue reported as short positions as of 24 Aug 2026, or about 23,448 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.57% in June 2022. LDX is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4LDX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Lumos Diagnostics Holdings
About
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss LDX
Start a research thread or post the first pulse update